KLT

基本解释

Conclusion:KLT could sensitize 95D cells to Gemzar in vitro.
康莱特先于健择加入对95D的抑制最强。
KLT could increase the sensitivity of Gemzar to 95D cells(P 康莱特先于健择加入对95D的抑制最强。
Official Title: Phase I Study of KLT in Patients With Solid Tumors Refractory to Standard Therapy.
题目全称:康莱特抗癌注射液在美国临床一期实验,对于目前的标准治疗来说,病人患有难治性实体肿瘤。
Phase I clinical trial in the us and basic studies of KLT in John Hopkins University.
康来特在中国临床三期实验。
Ruslts:Various concentration of KLT and Gemzar could inhibit the proliferation of 95D cells.
结果:康莱特单药对人肺腺癌95D的生长有抑制作用,联合健择的抑制率高于单药组;